The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

Cell

Volumn 84, Issue 4, 1996, Pages 587-597

  Ohta, Masataka ^a   Inoue, Hiroshi ^a,b   Cotticelli, Maria Grazia ^a,b   Kastury, Kumar ^a,b   Baffa, Raffaele ^a,b   Palazzo, Juan ^a   Siprashvili, Zurab ^a   Mori, Masaki ^b   McCue, Peter ^a   Druck, Teresa ^a   Croce, Carlo M ^a   Huebner, Kay ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 3P; CHROMOSOME TRANSLOCATION 3; COLON CARCINOMA; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; GASTROINTESTINAL CARCINOMA; GENE DELETION; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; PRIORITY JOURNAL; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 13344279424     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81034-X     Document Type: Article

References (37)

1. Boldog, F.L., Gemmill, R.M., Wilke, C.M., Glover, T.W., Nilsson, A.S., Chandrasekharappa, S.C., Brown, R.S., Li, F.P., and Drabkin, H.A. (1993). Positional cloning of the hereditary renal carcinoma 3;8 chromosome translocation breakpoint. Proc. Natl. Acad. Sci. USA 90, 8509-8513.
2. Boldog, F.L, Waggoner, B., Glover, T.W., Chumakov, I., Paslier, D., Cohen, D., Gemmill, R.M., and Drabkin, H.A. (1994). Integrated YAC contig containing the 3p14.2 hereditary renal carcinoma 3;8 translocation breakpoint and the fragile site FRA3B. Genes Chromosom. Cancer 11, 216-221.
3. Cohen, A.J., Li, F.P., Berg, S., Marchetto, D.J., Tsai, S., Jacobs, S.C., and Brown, R.S. (1979). Hereditary renal-cell carcinoma associated with a chromosomal translocation. N. Engl. J. Med. 301, 592-595.
4. Druck, T., Kastury, K., Hadaczek, P., Podolski, J., Toloczko, A., Sikorski, A., Ohta, M., LaForgia, S., Lasota, J., McCue, P., Lubinski, J., and Huebner, K. (1995). Loss of heterozygosity at the familial RCC t(3;8) locus in most clear cell renal carcinomas. Cancer Res. 55, 5348-5355.
5. Fong, L.Y.Y., Sivak, A., and Newberne, P.M. (1978). Zinc deficiency and methylbenzylnitrosaamine-induced esophageal cancer in rats. J. Natl. Cancer Inst. 61, 145-150.
6. Fu, Y-H., Kuhl, D.P.A., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, S., Verkerk, A.J.M.H., Holden, J J.A., Fenwick, R.G., Warren, S. T., Oostra, B.A., Nelson, D.L., and Caskey, C.T. (1991). Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67, 1047-1058.
7. Glover, T.W., Coyle-Morris, J.F, Brown, R.S., Berger, C.S., Gemmill, R.M., and Hecht, F. (1988). Translocation t(3;8)(p14.2;q24) in renal cell carcinoma affects expression of the common fragile site at 3p14 (FRA3B) in lymphocytes. Cancer Genet. Cytogenet. 31, 69-73.
8. Gnarra, J.R., Tory, K., Weng, Y., Schmidt, L., Wei, M.H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., Lubensky, I., Duan, D.R., Florence, C., Pozzatti, R., Walther, M.M., Bander, N.H., Grossman, H.B., Brauch, H., Pomer, S., Brooks, J.D., Isaacs, W.B., Lerman, M.I., Zbar, B., and Linehan, W.M. (1995). Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genet. 7, 85-90.
9. 4A) asymmetrical hydrolase: sequence similarity with the histidine triad (HIT) family. Biochem. J. 312, 925-932.
10. Jones, C., Slijepcevic, P., Marsh, S., Baker, E., Langdon, W.Y., Richards, R.I., and Tunnacliffe, A. (1994). Physical linkage of the fragile site FRA11B and a Jacobsen syndrome chromosome deletion breakpoint in 11q23.3. Hum. Mol. Genet. 3, 2123-2130.
11. Kastury, K. Baffa, R., Druck, T., Ohta, M., Cotticelli, M.G., Inoue, H., Negrini, M., Rugge, M., Huang, D., Croce, C.M., Palazzo, J., and Huebner, K. (1996a). Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. Cancer Res., in press.
12. Kastury, K., Ohta, M., Lasota, J., Moir, D., Dorman, T., LaForgia, S., Druck, T., and Huebner, K. (1996b). Structure of the human receptor tyrosine phosphatase γ gene (PTPRG) and relation to the familial RCC t(3;8) chromosome translocation. Genomics, in press.
13. n. Science 252, 1711-1714.
14. LaForgia, S., Morse, B., Levy, J., Barnea, G., Cannizzaro, L.A., Li, F., Nowell, P.C., Boghosian-Sell, L., Glick, J., Weston, A., Harris, C.C., Drabkin, H., Patterson, D., Croce, C.M., Schlessinger, J., and Huebner, K. (1991). Receptor protein-tyrosine phosphatase γ is a candidate tumor suppressor gene at human chromosome region 3p21. Proc. Natl. Acad. Sci. USA 88, 5036-5040.
15. LaForgia, S., Lasota, J., Latif, F., Boghosian-Sell, L., Kastury, K., Ohta, M., Druck, T., Atchison, L., Cannizzaro, L., Barnea, G., Schlessinger, J., Modi, W., Kuzmin, I., Tory, K., Zbar, B., Croce, C. M., Lerman, M., and Huebner, K. (1993). Detailed genetic and physical map of the 3p chromosome region surrounding the familial RCC chromosome translocation, t(3;8)(p14.2;q24.1). Cancer Res. 53, 3118-3124.
16. Li, F.P., Decker, H.J.H., Zbar, B., Stanton, V.P., Kovacs, G., Seizinger, B.R., Aburatani, H., Sandberg, A.A., Berg, S., Hosoe, S., and Brown, R.S. (1993). Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3;8 translocation. Ann. Intern. Med. 118, 106-111.
17. Lisitsyn, N.A., Lisitsina, N.M., Dalbagni, G., Barker, P., Sanchez, C.A., Gnarra, J., Linehan, W.M., Reid, B.J., and Wigler, M.H. (1995). Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc. Natl. Acad. Sci. USA 92, 151-155.
18. Lo, K.-W., Tsao, S.-W., Huang, D.P., and Lee, J.C.K. (1994). Detailed deletion mapping on the short arm of chromosome 3 in nasopharyngeal carcinomas. Int. J. Oncol. 4, 1359-1364.
19. Lubinski, J., Hadaczek, P., Podolski, J., Toloczko, A., Sikorski, A., McCue, P., Druck, T., and Huebner, K. (1994). Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas. Cancer Res. 54, 3710-3713.
20. Michaelis, S.C., Bardenheuer, W., Lux, A., Schramm, A., Gockel, A., Siebert, R., Willers, C., Schmidtke, K., Todt, B., van der Hout, A.H., Buys, C.H.C.M., Heppell-Parton, A.C., Rabbitts, P.H., Ungar, S., Smith, D., LePaslier, D., Cohen, D., Opalka, B., and Schütte, J. (1995). Characterization and chromosomal assignment of yeast artificial chromosomes containing human 3p13-p21-specific sequence tagged sites. Cancer Genet. Cytogenet. 81, 1-12.
21. Mozier, N.M, Walsh, M.P., and Pearson, J.D. (1991). Characterization of a novel zinc binding site of protein kinase C inhibitor-1. FEBS Lett. 279, 14-18.
22. Ohta, M., Berd, D., Shimizu, M., Nagai, H., Mastrangelo, M., Shields, J.A., Shields, C.L., Croce, C.M., and Huebner, K. (1995). Distinct common regions of deletion within chromosome region 9p21 in melanomas. Int. J. Cancer, in press.
23. Paradee, W., Mullins, C., He, Z., Glover, T., Wilke, C., Opalka, B., Schutte, J., and Smith, D. (1995). Precise localization of aphidicolin-induced breakpoints on the short arm of human chromosome 3. Genomics 27, 358-361.
24. Pearson, J.D., DeWald, D.B., Mathews, W.R., Mozier, N.M., Zurcher-Neely, H.A., Heinrikson, R.L., Morris, M.A., McCubbin, W.D., McDonald, J.R., Fraser, E.D., Vogel, H.J., Kay, C.M., and Walsh, M.P. (1990). Amino acid sequence and characterization of a protein inhibitor of protein kinase C. J. Biol. Chem. 265, 4583-4591.
25. Rassool, F.V., LeBeau, M.M., Neilly, M.E., Van Melle, E., Espinosa, R., and McKeithan, T.W. (1992). Increased genetic instability of the common fragile site at 3p14 after integration of exogenous DNA. Am. J. Hum. Genet. 50, 1243-1251.
26. Roche, J., Whisenant, E., Boldog, F., Loeb, D., Vance, J.M., and Drabkin, H. (1994). Dinucleotide repeats flanking the renal cell carcinoma breakpoint at 3p14.2. Hum. Mol. Genet. 3, 215.
27. Seraphin, B. (1992). The HIT protein family: a new family of proteins present in prokaryotes, yeast and mammals. DNA Seq. 3, 177-179.
28. Sutherland, G.R. (1991). Chromosomal fragile sites. Genet. Anal. Tech. Appl. 8, 1616-166.
29. 4-tetraphosphate pyrophosphohydrolase is a member of the MutT family of nucleotide pyrophosphatases. Biochem. J. 311, 717-721.
30. Verkerk, A.J.M.H., Pieretti, M., Sutcliffe, J.S., Fu, Y.-H., Kuhl, D.P.A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M.F., Zhang, F., Eussen, B.E., van Ommen, G.J.B., Blonden, L.A.J., Riggins, D.L., Chastain, J.L., Kunst, C.B., Galjaard, H., Caskey, C.T., Nelson, D.L., Oostra, B.A., and Warren, S.T. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-914.
31. Wang, N., and Perkins, K.L. (1984). Involvement of band 3p14in t(3;8) hereditary renal carcinoma. Cancer Genet. Cytogenet. 11, 479-481.
32. Wilke, C.M., Guo, S.-W., Hall, B.K., Boldog, F., Gemmill, R.M., Chandrasekharappa, S.C., Barcroft, C.L., Drabkin, H.A., and Glover, T.W. (1994). Multicolor FISH mapping of YAC clones in 3p14 and identification of a YAC spanning both FRA3B and the t(3;8) associated with hereditary renal cell carcinoma. Genomics 22, 319-326.
33. Yang, C.S. (1980). Research on esophageal cancer in China. Cancer Res. 40, 2633-2644.
34. Yang, G., Lipkin, M., Yang, K., Wang, G., Li, J., Yang, C., Winawer, S., Newmark, H., Biot, W.J., and Fraumeni, J.F., Jr. (1987). Proliferation of esophageal cells among residents of Linxian, People's Republic of China. J. Natl. Cancer Inst. 79, 1241-1246.
35. Yokota, J., Tsukada, Y., Nakajima, T., Gotoh, M., Shimosato, Y., Mori, N., Tsunokawa, Y., Sugimura, T., and Terada, M. (1989). Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res. 49, 3598-3601.
36. Yu, S., Pritchard, M., Kremer, E., Lynch, M., Nancarrow, J., Baker, E., Holman, K., Mulley, J.C., Warren, ST., Schlessinger, D., Sutherland, G.R., and Richards, R.I. (1991). Fragile X genotype characterized by an unstable region of DNA. Science 252, 1179-1181.
37. Yunis, J.J., and Soreng, A.L. (1984). Constitutive fragile sites and cancer. Science 226, 1199-1204.